-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Idexx Laboratories Inc /De annual Deferred Federal Income Tax Expense (Benefit) history and growth rate from 2016 to 2023.
- Idexx Laboratories Inc /De annual Deferred Federal Income Tax Expense (Benefit) for 2023 was -$36.5 M, a 15.3% decline from 2022.
- Idexx Laboratories Inc /De annual Deferred Federal Income Tax Expense (Benefit) for 2022 was -$31.7 M, a 351% decline from 2021.
- Idexx Laboratories Inc /De annual Deferred Federal Income Tax Expense (Benefit) for 2021 was -$7.02 M, a 50.3% increase from 2020.
Deferred Federal Income Tax Expense (Benefit), Annual (USD)
Deferred Federal Income Tax Expense (Benefit), YoY Annual Growth (%)